A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies
2017 ◽
Vol 170
◽
pp. 160-168
◽
2020 ◽
Vol 26
(37)
◽
pp. 4721-4737
◽
Keyword(s):
2007 ◽
Vol 16
(3)
◽
pp. 285-299
◽
Keyword(s):
2013 ◽
Vol 19
(1)
◽
pp. 92-94
◽
Keyword(s):
2005 ◽
Vol 21
(3)
◽
pp. 637-646
◽
Keyword(s):
1991 ◽
Vol 114
(2)
◽
pp. 184-192
◽
2008 ◽
Vol 115
(7)
◽
pp. 1001-1009
◽
Keyword(s):